A multicenter prospective observational study of ruxolitinib adherence in myelofibrosis and polycythemia vera
Latest Information Update: 23 Jan 2023
At a glance
- Drugs Ruxolitinib (Primary)
- Indications Myelofibrosis; Polycythaemia vera
- Focus Therapeutic Use
- Acronyms RAMP
Most Recent Events
- 23 Jan 2023 New trial record
- 13 Dec 2022 Results presented at the 64th American Society of Hematology Annual Meeting and Exposition